Auer W - Search Results

1

Induction of immune tolerance by oral IVIG.

Maier E, Reipert BM, Novy-Weiland T, Auer W, Baumgartner B, Muchitsch EM, Fiedler C, Grillberger L, Schwarz HP. Maier E, et al. Among authors: auer w. Int Immunopharmacol. 2007 Mar;7(3):351-9. doi: 10.1016/j.intimp.2006.11.007. Epub 2006 Dec 15. Int Immunopharmacol. 2007. PMID: 17276893

2

Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.

Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP. Reipert BM, et al. Among authors: auer w. Thromb Haemost. 2001 Dec;86(6):1345-52. Thromb Haemost. 2001. PMID: 11776297

3

Effects of alpha 1-acid glycoprotein in different rodent models of shock.

Muchitsch EM, Auer W, Pichler L. Muchitsch EM, et al. Among authors: auer w. Fundam Clin Pharmacol. 1998;12(2):173-81. doi: 10.1111/j.1472-8206.1998.tb00938.x. Fundam Clin Pharmacol. 1998. PMID: 9565771

4

Studies on the effect of human lys-plasminogen in a rat model of global cerebral ischemia.

Auer W, Muchitsch EM, Philapitsch A, Pichler L, Schwarz HP. Auer W, et al. Arzneimittelforschung. 1997 Nov;47(11):1195-9. Arzneimittelforschung. 1997. PMID: 9428972

5

Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.

Turecek PL, Gritsch H, Richter G, Auer W, Pichler L, Schwarz HP. Turecek PL, et al. Among authors: auer w. Thromb Haemost. 1997 Mar;77(3):591-9. Thromb Haemost. 1997. PMID: 9066015

6

Factor Xa and prothrombin: mechanism of action of FEIBA.

Turecek PL, Varadi K, Gritsch H, Auer W, Pichler L, Eder G, Schwarz HP. Turecek PL, et al. Among authors: auer w. Vox Sang. 1999;77 Suppl 1:72-9. doi: 10.1159/000056722. Vox Sang. 1999. PMID: 10529694

7

Phenotypic expression of murine hemophilia.

Muchitsch EM, Turecek PL, Zimmermann K, Pichler L, Auer W, Richter G, Gritsch H, Schwarz HP. Muchitsch EM, et al. Among authors: auer w. Thromb Haemost. 1999 Oct;82(4):1371-3. Thromb Haemost. 1999. PMID: 10544939 No abstract available.

8

In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease.

Turecek PL, Gritsch H, Pichler L, Auer W, Fischer B, Mitterer A, Mundt W, Schlokat U, Dorner F, Brinkman HJ, van Mourik JA, Schwarz HP. Turecek PL, et al. Among authors: auer w. Blood. 1997 Nov 1;90(9):3555-67. Blood. 1997. PMID: 9345039 Free article.

9

Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease.

Turecek PL, Pichler L, Auer W, Eder G, Varadi K, Mitterer A, Mundt W, Schlokat U, Dorner F, Drouet LO, Roussi J, van Mourik JA, Schwarz HP. Turecek PL, et al. Among authors: auer w. Blood. 1999 Sep 1;94(5):1637-47. Blood. 1999. PMID: 10477688 Free article.

10

Recombinant von Willebrand factor: preclinical development.

Plaimauer B, Schlokat U, Turecek PL, Mitterer A, Mundt W, Auer W, Pichler L, Gritsch H, Schwarz HP. Plaimauer B, et al. Among authors: auer w. Semin Thromb Hemost. 2001 Aug;27(4):395-403. doi: 10.1055/s-2001-16892. Semin Thromb Hemost. 2001. PMID: 11547362 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters